Skip to main content

Table 2 Multivariate analyses of prognostic factors for nasopharyngeal carcinoma

From: The goal of primary therapy in non-metastatic nasopharyngeal cancer should be radiological complete response

  5-year OS 5-year DMFS 5-year LRFFS
  Hazard ratio 95% Cl p Hazard ratio 95% Cl p Hazard ratio 95% Cl p
CR vs IR 0.13 0.045–0.036  < 0.001 0.26 0.095–0.744 0.012 0.78 0.34–1.24 0.18
Age 1.016 0.974–1,059 0.47 0.97 0.90–1.024 0.32 1.083 0.998–1.175 0.05
Gender (F/M) 0.99 0.2683.661 0.98 0.51 0.106–2.52 0.41 0.60 0.049–7.47 0.69
T stage (T1–2/T3–4a) 0.84 0.298–2.395 0.75 0.56 0.158–2.03 0.38 0.50 0.055–4.659 0.54
N stage N0 Reference Reference 0.46 - - - - - -
N1 3.32 0.363–30.45 0.28 - - - - - -
N2 3.95 0.479–32.65 0.20 - - - - - -
N3 8.13 0.597–110.86 0.11 - - - - - -
ECOG-PS 2.15 0.212–21.85 0.51 - - - - - -
Smoking 2.11 0.668–6.698 0.2 - - - - - -
Cisplatin dose with CRT (40 mg/m2 vs 100 mg/m2) 2.12 0.734–6.132 0.16 - - - - - -